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doi:10.1Objective: Aortic homografts were compared with pulmonary homografts in the setting of right ventricular
outflow tract reconstruction in adolescent sheep. Furthermore, clinically available stentless porcine and bovine
xenografts were studied as an alternative to homografts.
Methods: In 51 adolescent sheep cryopreserved aortic and pulmonary (ovine) homografts, as well as 6 different
types of clinically available stentless bioprostheses (Prima Plus, Toronto SPV, Toronto BiLinx, Freestyle, Peri-
carbon Stentless, and Contegra) were implanted in the pulmonary position. After 5 to 6 months, the valves were
explanted and studied for structural valve degeneration by means of radiographic analysis, histology, and
calcium content determination.
Results: Pulmonary homografts calcified significantly less than aortic homografts in the wall portion. Leaflet
calcification was mild, hardly detectable on radiographic analysis, and comparable between aortic and pulmo-
nary homografts. Stentless porcine xenografts showed severe calcification in the aortic wall portion, irrespective
of the antimineralization treatment. Leaflet calcification was mild and in the range of that seen in homografts.
Pannus formation was present but never induced leaflet retraction or cusp immobilization. Calcification was
absent in the stentless Pericarbon valve implants, but all valves showed extensive pannus overgrowth, leaflet
retraction, and cusp immobilization. The Contegra valves showed wall calcification, but the leaflets were
completely free of calcification and pannus.
Conclusions: For right ventricular outflow tract reconstruction, the pulmonary homograft remains the first
choice. All xenografts result in either calcific degeneration or cusp immobilization. (J Thorac Cardiovasc
Surg 2011;141:1513-21)Valved homografts have become the most commonly used
valved conduits for reconstruction of the right ventricular
outflow tract (RVOT) because stented xenografts develop
calcification, cusp tears, pannus formation, and typical
cusp immobilization.1-4 Recently, there is increasing
evidence in congenital heart surgery that aortic
homografts also calcify but faster and more significantly
compared with their pulmonary counterparts. Therefore
pulmonary homografts have become the conduit of choice
for RVOT reconstruction, especially in young children.4,5
However, given the relative shortage of small pulmonary
homografts, it was suggested that aortic homografts still
can be used in infants and older patients without
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SIt is the first goal of the present study to compare the cal-
cification potential of aortic versus pulmonary homografts
in an experimental setting in which growth and outgrowth
of the allografts do not play a role. We included a series
of aortic (ovine) homografts and a series of pulmonary ho-
mografts (originating from the same donor as their aortic
homograft counterparts) in our adolescent sheep model
experiments.6
On the other hand, more recently, several new types of
heterografts have been developed and promoted as alter-
natives to homografts and stented xenografts. Compared
with the older stented porcine heterografts mounted in
a Dacron conduit, stentless design and antimineralization
treatment render these new xenografts theoretically more
suitable candidates to replace homografts than the older
generation of conduits.6 Different models of stentless xe-
nografts are commercially available and clinically used.
We tested 6 of them in our adolescent sheep model: 4
of them are glutaraldehyde-fixed porcine roots, and the
other 2 are glutaraldehyde-fixed bovine tissue, either peri-
cardium or valved jugular vein. Several of these valves
are treated with an antimineralization treatment, although
others are not. It was the second goal of this study to
compare the calcification potential of these stentlessdiovascular Surgery c Volume 141, Number 6 1513
Abbreviations and Acronyms
DW ¼ dry weight
RVOT ¼ right ventricular outflow tract
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implants.
MATERIALS AND METHODS
Model
Fifty-eight Lovenaar sheep between 8 and 11 months of age (weighing
44.9  6.2 kg) were used in the study. The animals were bred at a special
unit of the Katholieke Universiteit Leuven and procured for research
through the Animalarium Katholieke Universiteit Leuven. The experi-
ments were approved by the Ethics Committee of the Katholieke Universi-
teit Leuven.
Seven animals were male and used as donors for allografts. They were
premedicated with ketamine (10–20 mg/kg administered intramuscularly),
and anesthesia was induced with increasing concentrations of isoflurane in
oxygen. After heparinization (3 mg/kg), they were killed with an overdose
of pentobarbital (Nembutal; Ovation Pharmaceuticals, Inc, Deerfield, Ill)
and KCl intravenously. The pulmonary and aortic roots were excised
from every sheep and cryopreserved as described below.7
Fifty-one animals were female and used as recipients for allografts or
xenografts. The animals were premedicated with ketamine (10–20 mg/kg
administered intramuscularly), and anesthesia was induced with increasing
concentrations of isoflurane in oxygen. Anesthesia was maintained with
isoflurane in 5 L/min O2 and 2 L/min N2O. A left thoracotomy was per-
formed, and after administration of heparin (3 mg/kg), the animal was
started on cardiopulmonary bypass. The main pulmonary artery was cross-
clamped, the native pulmonary valve was excised, and the pulmonary root
was replaced with either the allograft or the xenograft. After weaning from
bypass, the chest and surgical wounds were closed, mechanical ventilation
was discontinued, and the animal was allowed to recover.
At 5 to 6 months after surgical intervention, according to the protocol,
the animals were again anesthetized and killed after heparinization (3 mg/
kg) with an overdose of pentobarbital and KCl administered intravenously.
The implanted bioprosthesis was excised and analyzed as described below.
Bioprostheses
Two different types of allografts and 6 different types of xenografts were
implanted. The characteristics of these valves in terms of brand name, man-
ufacturer, number of implants, donor tissue, antimineralization treatment,
and tissue treatment are given in Table 1.TABLE 1. Valve types and characteristics
Valve type Manufacturer
Ovine homograft Aortic homograft European Homograft Bank, Bru
Pulmonary homograft European Homograft Bank, Bru
Porcine xenograft Prima Plus Edwards Lifesciences, Irvine, C
Toronto SPV St Jude Medical, Inc, St Paul, M
Toronto BiLinx St Jude Medical, Inc, St Paul, M
Freestyle Medtronic, Inc, Minneapolis, M
Bovine xenograft Pericarbon Sorin Biomedica, Saluggia, Ital
Contegra Medtronic, Inc, Minneapolis, M
1514 The Journal of Thoracic and Cardiovascular SurAllografts. The pulmonary and aortic roots from 7 donor sheep were
processed by the qualified personnel of the European Homograft Bank
(Brussels, Belgium).7 Exactly the same procedure of cryopreservation
was followed as is used for clinically available human homografts.7 The
allografts were sterilized in the antibiotic cocktail (Lincocin, Vancocin
and Polymixin B) over 20 to 48 hours and cryopreserved by using liquid
nitrogen with 10% dimethyl sulfoxide in Hanks’ solution as a cryoprotec-
tant, with controlled-rate freezing at 1C per minute down to40C and
5C per minute down to100C. They were stored in the vapors of liquid
nitrogen at a temperature of less than150C. Just before implantation,
they were thawed by means of rapid temperature increase according to
the European Homograft Bank protocol, and the dimethyl sulfoxide dilu-
tion was performed with isotonic solution (saline) in 4 steps of 1 minute
each, decreasing the dimethyl sulfoxide concentration from 10% to less
than 1%.
Xenografts. Six different types of clinically available stentless bio-
prostheses were used (Table 1). All valves were cross-linked with glutaral-
dehyde. Four types (Prima Plus, Toronto SPV, Toronto BiLinx, and
Freestyle) are porcine roots. The other 2 types were made from bovine
tissue (ie, bovine pericardium [Pericarbon] or bovine jugular vein
[Contegra]).
Explant Examination
After careful rinsing, gross examination of the explanted specimen was
performed, with special attention to vegetations, cuspal hematoma, throm-
bosis, stiffness of the wall portion, visible calcifications, cusp retraction,
tissue overgrowth (pannus), and leaflet tears and perforations.
Radiographic examinations were performed (Faxitron X-Ray, Lincoln-
shire, Ill), first in a horizontal plane perpendicular to the inflow–outflow
axis showing the leaflets. The root was then longitudinally sectioned
through the commissures, providing 3 wall portions, each containing one
leaflet. The 3 sections were unrolled in a single plane, and radiographs
were obtained.
Half of every section was used for calcium determination, and the rest
was used for histology and further Faxitron analysis. This means that a lon-
gitudinal section (thickness of 1 cm) was made, including leaflet and inflow
and outflow wall portions. Because this section and the histologic sections
were taken adjacently, comparison between radiographic and histologic
localization of calcifications became possible (Figure 1). For histology,
5-mm-thick sections were prepared, showing the entire wall and the leaflet
of the bioprosthesis (Figure 1). The sections were embedded in paraffin and
stained with hematoxylin and eosin, Masson’s trichrome stain for collagen,
Von Giesson stain for elastin, phosphotungstic acid–hematoxylin for fibrin,
and Von Kossa stain for calcium.
For quantitative calcium determination, half of every segment was used,
which means that 50% of the valve was analyzed for calcium content. The
tissue was divided into conduits and leaflets. The conduit wall was divided
into outflow and inflow portions. For quantification of the calcium content,No. of
implants
Antimineralization
treatment Tissue treatment
ssels, Belgium 7 None Cryopreservation
ssels, Belgium 6 None Cryopreservation
alif 8 Tween-80 Glutaraldehyde
inn 5 None Glutaraldehyde
inn 8 Ethanol (leaflets);
aluminum (wall)
Glutaraldehyde
inn 7 a-Amino oleic acid Glutaraldehyde
y 5 None Glutaraldehyde
inn 5 None Glutaraldehyde
gery c June 2011
FIGURE 1. Representative images from the postexplantation processing of all valves, with standardized cutting of the valves in segments, macroscopic
analysis (left panel), soft tissue radiographic analysis (middle panel), and histology (right panel).
Flameng et al Evolving Technology/Basic Sciencethe samples were lyophilized, weighed, and dissolved in 20% hydrochloric
acid solution (10 mg of dried tissue/mL of HCl) for 24 hours. After homog-
enization, samples were kept at 70Covernight. Samples were then analyzed
with a Calcium kit (Chema Diagnostica, Monsano, Italy) and a spectropho-
tometer (Multiscan EX; Thermo Electron Corp, Woburn, Mass). All values
are expressed in micrograms per milligram dry weight (DW).Calcium con
Ao_homo Pu_homo Prima Toronto
0
10
20
30
40
50
60
Ca
lci
u
m
 c
on
te
n
t (µ
g/m
g d
ry 
w
e
ig
ht
)
FIGURE 2. Calcium content values (median, interquartile range, and range) o
separate Mann–Whitney U tests) are reported in Table 2. Ao_homo, Aortic hom
The Journal of Thoracic and CarStatistical Analysis
Because the calcium content datawere abnormally distributed, nonpara-
metric statistics were used. Results are presented as themedian (minimum–
maximum). Comparisons among more than 2 groups were performed with
a Kruskal–Wallis test. If significance (P< .05) was observed, pairwise
comparisons of the groups were performed with nonpaired Mann–Whitneytent - Leaflet 
Bilinx Freestyle Pericarbon Contegra
 Median 
 25%-75% 
 Min-Max 
f leaflet tissue. Significant differences (Kruskal–Wallis testing followed by
ograft; Pu_homo, pulmonary homograft.
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TABLE 2. Statistical analysis of calcification in the leaflet
Prima Plus Toronto SPV Toronto BiLinx Freestyle Pericarbon Contegra
Ovine homografts
Aortic NS NS NS NS (>) P ¼ .03 (>) P ¼ .01
Pulmonary NS NS NS NS (>) P ¼ .05 (>) P ¼ .01
Porcine xenografts
Prima Plus – NS NS NS (>) P ¼ .01 NS
Toronto SPV NS – NS NS (>) P ¼ .01 (>) P ¼ .04
Toronto BiLinx NS NS – NS NS (>) P ¼ .008
Freestyle NS NS NS – (>) P ¼ .03 NS
Bovine xenografts
Pericarbon (<) P ¼ .01 (<) P ¼ .01 NS (<) P ¼ .03 – NS
Contegra NS (<) P ¼ .04 (<) P ¼ .008 NS NS –
(>) or (<), Calcium content data are higher or lower, respectively in the grafts listed at the left versus those listed at the top. NS, not significant (P>.1).
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greater than .1 are indicated as not significant.RESULTS
Valve Calcification
In the 3 parts of the valve (ie, the inflow tract, leaflets,
and outflow tract), calcification was documented on the ra-
diographic image (Faxitron, Figure 1) and on the histologic
section (Von Kossa staining). These observations were re-
lated to the quantitative data of the calcium content mea-
surements in the different samples. By using receiver
operating characteristic analysis, it was found that calcifi-
cation became detectable with radiographic analysis when
the calcium content in the samples exceeded 10.6 mg/mg
DW for the leaflets and 14 mg/mg DW for the wall. In the
histologic sections calcification became apparent at cal-
cium content values of 12.1 mg/mg DW for the leaflets
and 15 mg/mg DW for the wall. Because calcifications in
the low range (ie,<10–15 mg/mg DW) were not detected
by means of radiographic analysis or histology, all further
analysis of calcification will be based on the calcium
content data.
Leaflet calcification. The degree of calcification in the
leaflets differed significantly between the different typesTABLE 3. Statistical analysis of calcification in the inflow tract of the gra
Prima Plus Toronto SPV Toro
Ovine homografts
Aortic (>) P ¼ .02 (<) P ¼ .06 (>)
Pulmonary (<) P ¼ .05 (<) P ¼ .001 (<)
Porcine xenografts
Prima Plus – (<) P ¼ .001
Toronto SPV (>) P ¼ .001 – (>)
Toronto BiLinx NS (<) P ¼ .0007
Freestyle NS NS
Bovine xenografts
Pericarbon (<) P ¼ .06 (<) P ¼ .004
Contegra NS NS
(>) or (<), Calcium content data are higher or lower, respectively, in the grafts listed at th
1516 The Journal of Thoracic and Cardiovascular Surof grafts (P ¼ .03, Kruskal–Wallis test). Leaflets of aortic
or pulmonary homografts calcified to the same extent
(3.7 [1.5–6.9] vs 3.3 [2.1–14.3] mg/mg DW, P>.05), and
the level of calcification was comparable with that found
in porcine stentless xenografts (Figure 2 and Table 2). Leaf-
lets of stentless bovine xenografts calcified significantly
less than those of homografts and most stentless porcine
xenografts (Figure 2 and Table 2).
Wall calcification. In the inflow part, as well as the outflow
part, of the graft wall, the degree of calcification differed
significantly between different graft types (P ¼ .0003 and
P¼ .0005, respectively; Kruskal–Wallis test). Thewall por-
tions of aortic homografts calcified significantly more than
those of pulmonary homografts. This was the case for both
the inflow (25.5 [7.2–62.8] vs 3.9 [2.5–8.1] mg/mg DW,
P ¼ .005) and outflow (157.1 [106.7–205.2] vs 8.3
[1.3–38.1] mg/mg DW, P<.003) portions. Both the inflow
and outflow tracts of the wall in aortic homografts were
more calcified than that of stentless bovine xenografts and
most of the stentless porcine xenografts. In pulmonary ho-
mografts these wall portions were less calcified than those
in stentless porcine xenografts, and calcification was as
low as that seen in stentless bovine xenografts. The results
are presented in Tables 3 and 4 and Figures 3 and 4.ft wall
nto BiLinx Freestyle Pericarbon Contegra
P ¼ .009 NS (>) P ¼ .03 NS
P ¼ .04 NS NS NS
NS NS (>) P ¼ .006 NS
P ¼ .0007 NS (>) P ¼ .004 NS
– NS NS NS
NS – (>) P ¼ .05 NS
NS (<) P ¼ .05 – NS
NS NS NS –
e left versus those listed at the top. NS, Not significant (P>.1).
gery c June 2011
TABLE 4. Statistical analysis of calcification in the outflow tract of the graft wall
Prima Plus Toronto SPV Toronto BiLinx Freestyle Pericarbon Contegra
Ovine homografts
Aortic (>) P ¼ .01 (>) P ¼ .001 NS (>) P ¼ .03 (>) P ¼ .005 (>) P ¼ .02
Pulmonary (<) P ¼ .001 (<) P ¼ .001 (<) P ¼ .008 (<) P ¼ .01 NS NS
Porcine xenografts
Prima Plus – (>) P ¼ .01 NS NS (>) P ¼ .002 NS
Toronto SPV (<) P ¼ .01 – NS NS (>) P ¼ .001 NS
Toronto BiLinx NS NS – NS (>) P ¼ .004 NS
Freestyle NS NS NS – (>) P ¼ .01 NS
Bovine xenografts
Pericarbon (<) P ¼ .002 (<) P ¼ .001 (<) P ¼ .004 (<) P ¼ .01 – NS
Contegra NS NS NS NS NS –
(>) or (<), Calcium content data are higher or lower, respectively, in the grafts listed at the left versus those listed at the top. NS, Not significant (P>.1).
Flameng et al Evolving Technology/Basic ScienceAnalysis of Pannus Overgrowth
Pannus at the leaflets and cusp immobilization. Only the
Contegra valves were completely free of pannus at the leaf-
lets also at the ventricularis side. All other stentless xeno-
grafts showed pannus formation at the ventricularis side.
This was most pronounced in the aortic homografts and in
the Toronto BiLinx xenograft. None of the grafts showed
significant pannus formation at the fibrosa side of the leaf-
lets, with the exception of 2 stentless xenografts: the Prima
valve and the Pericarbon valve (Tables 5 and 6). The
Pericarbon valve was the only valve with pannus formation
at both sides of the leaflets, which was so aggressive that
it was associated with attraction of the cusps and adhesion
of the leaflets to the conduit wall, resulting in cusp
immobilization. This induced stenosis and severeCalcium conten
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FIGURE 3. Calcium content values (median, interquartile, range and range) o
(Kruskal–Wallis testing followed by separate Mann–Whitney U tests) are r
homograft.
The Journal of Thoracic and Carincompetence of the valve. Figure 5 shows a typical example
of this complication. The results are shown in Tables 5 and 7.
Pannus at the wall portion. At the inflow side of the wall
portion, all homografts and stentless xenografts had pannus
formation, and there was no significant difference in its in-
cidence between valve types (P>.05). The same was found
at the outflow side of the wall portion with one exception:
the Toronto BiLinx valve. This valve showed significantly
less pannus than both homograft types, the Prima valve
and the Freestyle xenografts (P < .05). The results are
shown in Table 5.
DISCUSSION
Although the development of cryopreservation tech-
niques combined with improved availability has resultedt - Wall, inflow part
Bilinx Freestyle Pericarbon Contegra
 Median 
 25%-75% 
 Min-Max 
f wall tissue, more specifically the inflow portion. Significant differences
eported in Table 3. Ao_homo, Aortic homograft; Pu_homo, pulmonary
diovascular Surgery c Volume 141, Number 6 1517
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Calcium content - Wall, outflow part
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FIGURE 4. Calcium content values (median, interquartile, range and range) of wall tissue, more specifically the outflow portion. Significant differences
(Kruskal–Wallis testing followed by separate Mann–Whitney U tests) are reported in Table 4. Ao_homo, Aortic homograft; Pu_homo, pulmonary
homograft.
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the RVOT in patients with congenital heart disease,4 their
durability is limited and was shown to be adversely affected
by several factors, including younger age and smaller ho-
mograft size at implantation. Outgrowth of the homograft
valves appears to be an important cause of homograft fail-
ure.4 Also, the type of homograft (aortic or pulmonary)
was suggested as a factor of reduced durability,4,8
although others could not confirm this.9 Size and outgrowth
seem to overwhelm homograft type as a predictor of fail-
ure.10 Obviously, outgrowth results in patient–prosthesis
mismatch, which plays a significant role in structural valve
deterioration, as we recently showed for aortic valve
bioprostheses.11 To avoid outgrowth, we tested aortic and
pulmonary homografts in the RVOT position in anTABLE 5. Incidence of pannus formation in the valve leaflets and wall
portion
Fibrosa Ventricularis Inflow Outflow
Ovine homografts
Aortic 0/7 7/7 7/7 7/7
Pulmonary 0/6 5/6 6/6 6/6
Porcine xenografts
Prima Plus 6/8 3/8 6/8 8/8
Toronto SPV 2/5 2/5 5/5 3/5
Toronto BiLinx 0/8 8/8 8/8 3/8
Freestyle 0/7 5/7 7/7 7/7
Bovine xenografts
Pericarbon 5/5 2/5 5/5 5/5
Contegra 0/5 0/5 5/5 4/5
1518 The Journal of Thoracic and Cardiovascular Surexperimental model of adolescent sheep. In adolescent
sheep (age range, 8–11 months), in contrast to juvenile
sheep, growth slowed down already to such an extent that
outgrowth and mismatch of the valve do not occur anymore.
On the other hand, calcification potential is maintained in
this model.6 By doing so, we could clearly show that aortic
homografts calcify significantly more than pulmonary ho-
mografts. Because in our model both the aortic and pulmo-
nary homografts originated from the same donor, the basic
mechanism of this difference in calcification potential must
be searched in the intrinsic difference of tissue structure be-
tween aortic and pulmonary grafts. Although we found that
pulmonary homografts calcify less than aortic homografts,
they still calcified to a certain extent. This was also de-
scribed by Hopkins and colleagues,12 although they used
a juvenile sheep model. In the clinical setting it was shown
that in infants the most common indication for reoperation
in patients receiving cryopreserved pulmonary valve allo-
grafts to repair their RVOTs is allograft fibrocalcification
and valve insufficiency.13
For reconstruction of the RVOT in patients with congeni-
tal heart disease, allografts have the reputation of better long-
term durability than xenografts.9,14,15 These observations
were based on the use of stented porcine xenografts
mounted in Dacron conduits or orthotopic implants of
stented xenografts. In a recent study Soor and associates1 re-
viewed the morphologic findings in 40 cases of pulmonary
site bioprostheses. This study included pulmonary valves
in conduits, as well as orthotopically implanted valves.
The valves were all stented valves, be they porcine or bovinegery c June 2011
TABLE 6. Statistical analysis of pannus formation on the fibrosa side of the leaflets
Prima Plus Toronto SPV Toronto BiLinx Freestyle Pericarbon Contegra
Ovine homografts
Aortic (<) P ¼ .007 NS NS NS (<) P ¼ .001 NS
Pulmonary (<) P ¼ .01 NS NS NS (<) P ¼ .002 NS
Porcine xenografts
Prima Plus – NS (>) P ¼ .007 (>) P ¼ .007 NS (>) P ¼ .02
Toronto SPV NS – NS NS NS NS
Toronto BiLinx (<) P ¼ .07 NS – NS (<) P ¼ .001 NS
Freestyle (<) P ¼ .07 NS NS – (<) P ¼ .001 NS
Bovine xenografts
Pericarbon NS NS (>) P ¼ .001 (>) P ¼ .001 – (>) P ¼ .008
Contegra (<) P ¼ .02 NS NS NS (<) P ¼ .008 –
(>) or (<), Calcium content data are higher or lower, respectively, in the grafts listed at the left versus those listed at the top. NS, Not significant (P>.1).
Flameng et al Evolving Technology/Basic Sciencepericardial valves. All these explants had 3 pathologic fea-
tures in common: cusp calcification in 80% of the valves,
tears in 47.5%, and pannus or host tissue overgrowth in
97.5%. Cusp immobilization by pannus overgrowth and
leaflet retraction was common in patients younger than
30 years and typically contributed to valve stenosis and in-
competence. It was also recognized by others that stented
porcine valves calcified, and when they were included in
a conduit, the Dacron graft developed a pseudointimal peel
that could result in stenosis of small-diameter conduits.4,14,15
The development of stentless xenografts opened new per-
spectives because the design of these xenografts resembles
that of homografts. Recently, the Freestyle porcine aorticFIGURE 5. Representative histologic examples from explanted stentless Peric
zation are shown. Left panel, Moderate pannus formation with immobilization
cusp retraction.
The Journal of Thoracic and Carroot has been used clinically for RVOT reconstruction in
children. Short-term and midterm results are encouraging,
showing a low incidence of pulmonary insufficiency and
minimal pressure gradients across the RVOT.16-19
However, isolated cases of leaflet stenosis were
reported,17 eventually leading to reoperation.19 In one re-
port the peak pressure gradient across the Freestyle valve
was followed over time and was shown to increase from
12.1  11 mm Hg at discharge to 24.1  20 mm Hg after
51 months.19 Such findings raise questions about the long-
term durability of these stentless xenografts. Our experi-
mental data in the accelerated calcification model of
chronic sheep implants show that leaflets of stentlessarbon valves. Different degrees of pannus formation with cusp immobili-
of the lower third of the cusp; right panel, severe pannus with complete
diovascular Surgery c Volume 141, Number 6 1519
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TABLE 7. Statistical analysis of pannus formation on the ventricularis side of the leaflets
Prima Plus Toronto SPV Toronto BiLinx Freestyle Pericarbon Contegra
Ovine homografts
Aortic (>) P ¼ .02 (>) P ¼ .01 NS NS (>) P ¼ .04 (>) P ¼ .001
Pulmonary NS NS NS NS NS (>) P ¼ .01
Porcine xenografts
Prima Plus – NS (<) P ¼ .02 NS NS NS
Toronto SPV NS – (<) P ¼ .03 NS NS NS
Toronto BiLinx (>) P ¼ .02 (>) P ¼ .03 – NS (>) P ¼ .03 (>) P ¼ .001
Freestyle NS NS NS – NS (>) P ¼ .02
Bovine xenografts
Pericarbon NS NS (<) P ¼ .03 NS – NS
Contegra NS NS (<) P ¼ .001 (<) P ¼ .02 NS –
(>) or (<), Calcium content data are higher or lower, respectively, in the grafts listed at the left versus those listed at the top. NS, Not significant (P>.1).
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the same extent as those of homografts. This leaflet calcifi-
cation, however, remains mild in contrast to the severe cal-
cification found in stented pulmonary valves implanted in
the same animal model.6 However, calcification in the
wall portion of stentless porcine roots was significant.
These are most probably due to the typical highly cellular-
ized structure of the aortic wall, which contains more elas-
tin. Obviously none of the antimineralization treatments
were able to mitigate the extensive calcifications in the
wall portions of the valves, be it a-oleic acid, aluminum,
or Tween-80. The only significant effect of an antimineral-
ization treatment we could show was that of aluminum
preventing pannus formation in the outflow part of the
porcine Toronto BiLinx valve.
At present, the basic mechanism of tissue calcification in
xenografts is not completely elucidated, but we know that it
is determined by many independent factors, such as the age
of the recipient, implant position (left or right sided), pros-
thesis design (stented or stentless), and tissue structure (por-
cine vs pericardial and wall portion vs cusp).6 It is hard to
tell which of these factors is the most important in terms
of calcification potential, but younger age at implantation
will certainly play a major role. Older age at implantation
can definitely explain the superior results of RVOT recon-
struction during Ross aortic valve replacement in young
adults compared with results in those with complex congen-
ital RVOT obstruction.19,20
An interesting finding in this series of stented xenografts
is their low incidence or even absence of cusp tears. It might
of course be related to the decreased pressures in the right
side of the heart compared with the left side. On the other
hand, it has been suggested that pannus formation on the
cusps provides a coating or sheath to the bioprosthetic
cusps, thus protecting them from collagen fiber damage
that would normally cause tearing.1
Cusp immobilization by pannus overgrowth, which is al-
most classically seen in stented pulmonary site xenografts,
leading to so-called open regurgitation,21,22 was only found1520 The Journal of Thoracic and Cardiovascular Surin one of the tested stentless xenografts: the Pericarbon
stentless valve. In contrast to the Freestyle, Contegra,
and Toronto valves, this valve developed pannus not only
at the ventricularis side but also at the fibrosa side, which
induced leaflet overgrowth, retraction, and cusp
immobilization. It is remarkable that these valves did not
calcify at all and showed the lowest calcium contents in
all portions. Cusp immobilization reduces stress on the
leaflets and the conduit to such an extent that, most
probably, calcification of the valves was prevented.
Among the stentless xenografts tested in this series, the
bovine jugular vein valved conduit Contegra showed the
best results. The cusps remained completely free of calcifi-
cation and pannus formation, and the degree of conduit cal-
cification was moderate. These results are confirmed by
midterm outcome studies in pediatric and adult patients,
showing that the durability of the Contegra conduit com-
pares well with that of homografts.23-25 However, in some
series severe stenosis at the level of the distal anastomosis
was reported, leading to reoperation.26,27 The origin of
this unpredictable incidence of supravalvular stenosis is
not yet elucidated. It was never encountered in our
experimental model and might be related to the use of
surgical techniques or materials to construct the distal
anastomosis. Besides the supravalvular stenosis, wall
calcification was found in early to midterm human
explants.27
In summary, this experimental study clearly shows the
superiority of pulmonary over aortic homografts for
RVOT reconstruction. Stentless porcine xenografts and
the bovine jugular vein conduit are acceptable alternatives
because they have low cusp calcification and no leaflet tear-
ing or cusp immobilization. However, significant wall calci-
fication develops in spite of any anticalcification treatment.References
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